Premier Path Wealth Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Sell |
31,538
-2,173
| -6% | -$83.4K | 0.17% | 143 |
|
|
2025
Q1 | $1.31M | Sell |
33,711
-563
| -2% | -$21.8K | 0.2% | 124 |
|
|
2024
Q4 | $1.16M | Buy |
34,274
+5,967
| +21% | +$202K | 0.18% | 139 |
|
|
2024
Q3 | $1.16M | Buy |
28,307
+1,239
| +5% | +$50.6K | 0.18% | 144 |
|
|
2024
Q2 | $1.04M | Buy |
27,068
+1,148
| +4% | +$44.2K | 0.18% | 143 |
|
|
2024
Q1 | $1.11M | Buy |
25,920
+3,869
| +18% | +$166K | 0.21% | 128 |
|
|
2023
Q4 | $828K | Buy |
+22,051
| New | +$828K | 0.18% | 141 |
|